Vol.

No.

February 05, 2021Feb 05, 2021

Free

DOWNLOAD THE PDF

Jill Biden signals White House resolve on cancer research: “This is the fight of our lives”

Cover Story

Free

Jill Biden signals White House resolve on cancer research: “This is the fight of our lives”

By Matthew Bin Han Ong

Jill Biden stopped by at NCI earlier this week to reaffirm the Bidens' pledge to “fight cancer as we know it”—an early signal that cancer research is near the top of the national agenda at the Biden-Harris White House.

Free Guest Editorial

Building on the legacy of the Beau Biden Cancer Moonshot

By Robert H. Vonderheide

Free

Storytelling is a part of J Freireich's legacy

By Paul Goldberg

Free

Legendary MD Anderson faculty member Emil J Freireich dies at 93

By MD Anderson Cancer Center staff

Free Obituary

Ode to J
“On our best days, we could only wish to be what Freireich was on any one of his average days”

By Hagop M. Kantarjian

Free Obituary

J Freireich loved good science and a good fight

By Moshe Talpaz

Free Obituary

J Freireich was one of the few oncologists to have developed a cancer cure

By Otis W. Brawley

Conversation with The Cancer Letter Free

For those watching The Crown:
Remember when Princess Diana raised money for Northwestern Cancer Center?

By Paul Goldberg

Free In the Archives

Black History Month, the National Cancer Act—and opening up the archives

Clinical Free Trials & Tribulations

The Delaware experience:
Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19

By Nicholas J. Petrelli, Nora Katurakes, Rose Mili and Charlene Marinelli

In Brief

Jeremy Rich named deputy director of research at UPMC Hillman Cancer Center

Yen-Michael Hsu named director for cell therapy laboratory at UPMC Hillman

Jeffrey Bradley named interim chair of Emory Department of Radiation Oncology

ASCO 2021 annual meeting to be virtual

Roswell Park, BMS Foundation create $3.3 million program to address cancer burden for native and rural communities

Clinical Roundup

More than half of cancer survivors have underlying medical conditions associated with severe COVID-19

Gene mutations linked to worse outcomes from leukemia in Hispanic and Latino children

Queen's leading new research aimed at improving outcomes for early-stage bowel cancer

Yale Cancer Center researchers discover mechanism to overcome drug-resistance in B-ALL

IU cancer center researchers discover how breast cancer cells hide from immune attack

Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy

Targeted RNA nanoparticle shows early promise as liver cancer treatment

KEYNOTE-598: Keytruda + Yervoy did not improve OS, PFS in Non-Small Cell Lung Cancer

Drugs & Targets

FDA grants accelerated approval to Tepmetko for metastatic NSCLC

Keytruda receives positive EU CHMP opinion for expanded approval in some cases of relapsed or refractory classical hodgkin Lymphoma

NCI Trials

NCI Trials for February 2021

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 51 | Issue 35 - September 26, 2025

Jill Biden signals White House resolve on cancer research: “This is the fight of our lives”

Building on the legacy of the Beau Biden Cancer Moonshot

Storytelling is a part of J Freireich's legacy

Legendary MD Anderson faculty member Emil J Freireich dies at 93

Ode to J
“On our best days, we could only wish to be what Freireich was on any one of his average days”

J Freireich loved good science and a good fight

J Freireich was one of the few oncologists to have developed a cancer cure

For those watching The Crown:
Remember when Princess Diana raised money for Northwestern Cancer Center?

Black History Month, the National Cancer Act—and opening up the archives

The Delaware experience:
Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19

In Brief

Jeremy Rich named deputy director of research at UPMC Hillman Cancer Center

Yen-Michael Hsu named director for cell therapy laboratory at UPMC Hillman

Jeffrey Bradley named interim chair of Emory Department of Radiation Oncology

ASCO 2021 annual meeting to be virtual

Roswell Park, BMS Foundation create $3.3 million program to address cancer burden for native and rural communities

Clinical Roundup

More than half of cancer survivors have underlying medical conditions associated with severe COVID-19

Gene mutations linked to worse outcomes from leukemia in Hispanic and Latino children

Queen's leading new research aimed at improving outcomes for early-stage bowel cancer

Yale Cancer Center researchers discover mechanism to overcome drug-resistance in B-ALL

IU cancer center researchers discover how breast cancer cells hide from immune attack

Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy

Targeted RNA nanoparticle shows early promise as liver cancer treatment

KEYNOTE-598: Keytruda + Yervoy did not improve OS, PFS in Non-Small Cell Lung Cancer

Drugs & Targets

FDA grants accelerated approval to Tepmetko for metastatic NSCLC

Keytruda receives positive EU CHMP opinion for expanded approval in some cases of relapsed or refractory classical hodgkin Lymphoma

NCI Trials

NCI Trials for February 2021

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login